upcyte head welcome

upcyte® Liver Sinusoidal Endothelial Cells


LSECsLiver sinusoidal endothelial cells (LSECs) are highly specialized cells that form the scavenger endothelium within the liver. They exhibit extraordinarily high uptake of soluble waste molecules (< 0.23 µm), thus playing an important role in blood clearance.

The supply of primary LSECs is limited by the low and sporadic availability of human liver tissue and can only be kept for up to 1-2 population doublings in culture.

upcyte® LSECs were derived from primary LSECs from a single donor. These cells have an extended lifespan whilst maintaining primary cell characteristics. This means that large batches of up to 3000 vials from a single donor with the same quality can be provided (cryo-vials with 2x106 or 5x106 frozen cells per vial).

upcyte® LSECs have been tested for numerous cel type specific markers, scavenging / uptake functions, as well as the ability to form tubes in matrigel. The cells exhibit a similar sensitivity to primary cells making them the ideal tool to study toxicity and to set-up co-culture models to generate a more predictive in vitro system. These cells can be used for screening to exclude compounds at an early stage meaning toxic compounds do not reach animal testing and clinical stages.

If you need advice – theoretical or practical - our specialists are pleased to offer support and demonstrate the handling of upcyte® LSECs in your own lab.

Benefits of upcyte® LSECs at a glance:

  • three different donors available
  • batch sizes up to 3000 vials per donor
  • primary cell morphology
  • long term cultures for up to 4 weeks
  • characterized, standardized, cryopreserved, assay-ready

upcyte® LSECs have been tested at each expansion state for:

  • cell morphology
  • viable recovery
  • markers: CD31+, MMR+ (Mannose receptor)

Please note: these cells are offered in a ready to use format. Further expansion will lead to the cells expressing senescence genes and the phenotype is lost.


In addition whole genome expression profiling revealed that upcyte® LSECs and primary LSECs have similar expression profile. Only 0.45% (218) of a total of 48,107 gene probes analyzed have been found to be up- or down-regulated more than 2-fold.

For each product a protocol for use and a certificate of analysis will be delivered. All cells have been tested for the absence of CMV, HIV, Hepatitis B and C and microbial contaminants (fungi, bacteria and mycoplasma). upcyte® cells are genetically modified cells (GMO, genetically modified organism) classified as risk group 1 and have to be handled in a genetic engineering facility carrying out genetic engineering work at Security Level 1 (e.g. S1 lab). upcyte® Hepatocytes and upcyte® Endothelial Cells are officially classified as risk group 1 organisms by the German Federal Office of Consumer Protection and Food Safety (BVL) and the Central Committee on Biological Safety (ZKBS). For further information please use the following link and enter “upcyte” in the search boxlink.

© 2018 by upcyte technologies GmbH // Osterfeldstrasse 12-14 // 22529 Hamburg // Germany